Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

24,446 total articles

Youxin Technology Signs Cooperation Intention Agreement to Join Guangzhou's Citywide Government AI Hub Initiative “SuiZhiZheng” as an Ecosystem Partner

Youxin Technology Signs Cooperation Intention Agreement to Join Guangzhou's Citywide Government AI Hub Initiative “SuiZhiZheng” as an Ecosystem Partner

Youxin Technology Ltd announced that its subsidiary has signed a cooperation intention agreement to join Guangzhou's citywide government AI platform initiative, SuiZhiZheng. This marks the company's potential expansion from retail digital transformation services into government AI applications, leveraging its expertise in data governance and automa…

Cardiff Oncology Announces $10 Million Registered Direct Offering

Cardiff Oncology Announces $10 Million Registered Direct Offering

Cardiff Oncology, a clinical-stage biotech company focused on PLK1 inhibition for cancer treatment, has entered into definitive agreements for a $10 million registered direct offering of common shares and warrants. The proceeds will be primarily used for working capital and general corporate purposes to support ongoing clinical trials, especially o…

UroGen Receives New U.S. Patent Allowance Expected to Provide Protection into July 2044 for ZUSDURI™ and UGN-103

UroGen Receives New U.S. Patent Allowance Expected to Provide Protection into July 2044 for ZUSDURI™ and UGN-103

UroGen Pharma Ltd. announced the receipt of a U.S. patent allowance for methods treating low-grade intermediate-risk non-muscle invasive bladder cancer (LG-IR-NMIBC) using its proprietary RTGel technology delivering mitomycin. The patent protection is expected to extend until July 2044, reinforcing the intellectual property foundation for its FDA-a…

ENvue Medical Appoints Chairman of the Board and New Directors, Bringing Clinical, AI Governance and Capital Markets Expertise to Navigation Platform

ENvue Medical Appoints Chairman of the Board and New Directors, Bringing Clinical, AI Governance and Capital Markets Expertise to Navigation Platform

ENvue Medical has appointed Dr. Zeev Rotstein as Chairman of the Board and added Zvi Joseph and Lior Buchman as new directors, bringing extensive expertise in healthcare leadership, AI governance, and capital markets. These strategic board changes support ENvue's momentum in advancing its real-time guided bedside feeding tube placement technology a…

Ernexa Therapeutics Receives Independent Validation of ERNA-101 with Complete Tumor Clearance and Durable Survival in Ovarian Cancer Models Ahead of Planned Clinical Entry

Ernexa Therapeutics Receives Independent Validation of ERNA-101 with Complete Tumor Clearance and Durable Survival in Ovarian Cancer Models Ahead of Planned Clinical Entry

Ernexa Therapeutics announced independent validation of its lead cell therapy candidate ERNA-101 in combination with anti-PD-1 treatment, achieving complete tumor clearance and long-term survival in 67% of treated animals in ovarian cancer models. No complete responses were observed in monotherapy or control groups. This robust third-party study en…

Profound Medical: Autonomous Robotics and Incisionless Surgery to Have Exceptional Presence at SRS2026

Profound Medical: Autonomous Robotics and Incisionless Surgery to Have Exceptional Presence at SRS2026

Profound Medical Corp. announced its advanced MRI-guided, AI-powered, robotically-driven TULSA Procedure for incisionless prostate ablation will be featured prominently at the Society of Robotic Surgery Annual Meeting (SRS2026). The company will participate in multiple presentations, including clinical outcomes and safety data, as well as an invest…

Repligen to Report Second Quarter 2026 Financial Results

Repligen to Report Second Quarter 2026 Financial Results

Repligen Corporation, a life sciences company specializing in bioprocessing technologies, announced it will report its second quarter 2026 financial results on July 28, 2026. A conference call and webcast will follow to discuss business updates and financial outcomes for the quarter ending June 30, 2026.

Cellectar Biosciences Announces Publication of Phase 1 Study of Iopofosine I 131 in Peer-Reviewed Journal Cancers

Cellectar Biosciences Announces Publication of Phase 1 Study of Iopofosine I 131 in Peer-Reviewed Journal Cancers

Cellectar Biosciences announced the publication of the Phase 1 study results of iopofosine I 131 combined with low-dose dexamethasone in heavily pretreated relapsed/refractory multiple myeloma patients. The study demonstrated a manageable safety profile with predominantly hematologic toxicities and showed encouraging clinical activity, supporting c…

Acumen Pharmaceuticals Highlights Enhanced Brain Delivery™ (EBD™) Program Data and Early Alzheimer’s Disease Insights at the Alzheimer’s Association International Conference (AAIC®) 2026

Acumen Pharmaceuticals Highlights Enhanced Brain Delivery™ (EBD™) Program Data and Early Alzheimer’s Disease Insights at the Alzheimer’s Association International Conference (AAIC®) 2026

Acumen Pharmaceuticals presented new preclinical data demonstrating that their Enhanced Brain Delivery™ (EBD™) bispecific antibodies achieved markedly improved brain penetration in non-human primates compared to native antibodies. Notably, candidate ACU401 showed up to 40-fold higher frontal cortex exposure with no hematological safety concerns, su…

TappAlpha Expands Growth + Income ETF Platform with TMGN, Bringing Tax-Efficient Income to the Cboe Magnificent 10 Index

TappAlpha Expands Growth + Income ETF Platform with TMGN, Bringing Tax-Efficient Income to the Cboe Magnificent 10 Index

TappAlpha has introduced the TappAlpha Cboe Magnificent 10 Growth & Daily Income ETF (TMGN), an options-overlay ETF providing exposure to the equal-weighted Cboe Magnificent 10 Index. The fund aims to deliver growth and tax-efficient daily income by combining key mega-cap growth stocks with a disciplined options strategy, expanding TappAlpha's Grow…

Sify reports Consolidated Financial Results for Q1 FY 2026-27

Sify reports Consolidated Financial Results for Q1 FY 2026-27

Sify Technologies Limited announced its consolidated financial results for Q1 FY 2026-27, reporting a 15% year-over-year revenue increase to INR 12,352 million and a 42% rise in adjusted EBITDA to INR 3,005 million. The company continues to invest heavily in data center capacity, network modernization, and digital platforms to support rising demand…

IREN Appoints Chief Information Security Officer

IREN Appoints Chief Information Security Officer

IREN Limited, a vertically integrated AI cloud platform provider, announced the appointment of Eric Hammersley as Chief Information Security Officer to lead security efforts across its data centers, compute, and software layers. This follows recent senior executive additions amid IREN's expansion of its AI cloud platform in various markets. Hammers…